Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ASSEMBLY BIOSCIENCES, INC. Director's Dealing 2021

May 24, 2021

33081_dirs_2021-05-24_f52dcff6-e9b2-4488-a28b-eda2bfb4d71e.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ASSEMBLY BIOSCIENCES, INC. (ASMB)
CIK: 0001426800
Period of Report: 2021-05-20

Reporting Person: Consylman Gina (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2021-05-20 Stock Option (right to buy) $4.03 A 15000 Acquired 2031-05-20 Common Stock (15000) Direct

Footnotes

F1: Grant of stock options. The stock options vest, assuming continuous service, upon the earlier of (1) May 20, 2022 and (2) the date of the Issuer's 2022 annual meeting of stockholders.